BMC Genomics · 2019 · 12 citations · 42 references
MedicineGeneticsMolecular GeneticsHuman GeneticsMitochondrial BiologyMitochondrial GeneticsMitochondrial Genome VariationMitochondrial HaplogroupsRare Variant AnalysisCommon Genetic VariantsCompetitive AthletesDisease-causing VariantsMitochondrial Dna GeneticsMitochondrial Dna MutationsMitochondrial Dna Sequence VariationMitochondrial Dna VariationMutational Load
BACKGROUND: We have previously reported on paucity of mitochondrial DNA (mtDNA) haplogroups J and K among Finnish endurance athletes. Here we aimed to further explore differences in mtDNA variants between elite endurance and sprint athletes. For this purpose, we determined the rate of functional variants and the mutational load in mtDNA of Finnish athletes (n = 141) and controls (n = 77) and determined the sequence variation in haplogroups. RESULTS: The distribution of rare and common functional variants differed between endurance athletes, sprint athletes and the controls (p = 0.04) so that rare variants occurred at a higher frequency among endurance athletes. Furthermore, the ratio between rare and common functional variants in haplogroups J and K was 0.42 of that in the remaining haplogroups (p = 0.0005). The subjects with haplogroup J and K also showed a higher mean level of nonsynonymous mutational load attributed to common variants than subjects with the other haplogroups. Interestingly, two of the rare variants detected in the sprint athletes were the disease-causing mutations m.3243A > G in MT-TL1 and m.1555A > G in MT-RNR1. CONCLUSIONS: We propose that endurance athletes harbor an excess of rare mtDNA variants that may be beneficial for oxidative phosphorylation, while sprint athletes may tolerate deleterious mtDNA variants that have detrimental effect on oxidative phosphorylation system. Some of the nonsynonymous mutations defining haplogroup J and K may produce an uncoupling effect on oxidative phosphorylation thus favoring sprint rather than endurance performance.
42
Sequence and organization of the human mitochondrial genome
Stephen K. Anderson, Alan T. Bankier, B. G. Barrell et al. · Nature · 1981 · 9.7K citations
Hypoxia as a therapy for mitochondrial disease
Isha H. Jain, L. Zazzeron, Rahul Goli et al. · Science · 2016 · 449 citations · Full text